imipramine has been researched along with 1-naphthylamine in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.67) | 18.7374 |
| 1990's | 26 (86.67) | 18.2507 |
| 2000's | 1 (3.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Bach, A; Brambilla, R; Carmona, RMC; Desu, HL; Gajhede, M; Garcia, AD; Høj, LJ; Johansen, TN; Marseglia, G; Munafò, F; Narayanan, D; Pallesen, JS; Popowicz, GM; Sattler, M; Solbak, SMØ; Sørensen, LME; Tran, KT | 1 |
| Broekkamp, CL; Jenck, F; Van Delft, AM | 1 |
| Koe, BK; Lebel, LA; Welch, WM | 1 |
| Aronson, CE; Brunswick, DJ; Frazer, A; Kovachich, GB | 1 |
| Phillips, OM; Williams, DC; Wood, KM | 1 |
| Fawcett, JA; Gelenberg, A; Harrison, W; Hirschfeld, RM; Keller, MB; Klein, D; Kocsis, JH; McCullough, JP; Rush, AJ; Schatzberg, A | 1 |
| Duman, RS; Morinobu, S; Nibuya, M | 1 |
| Auerbach, SB; Hjorth, S; Lundberg, JF | 1 |
| Preskorn, SH | 1 |
| Helmeste, DM; Reist, C; Tang, SW; Vu, R | 1 |
| Alpert, JE; Fava, M; Maddocks, A; Rosenbaum, JF | 1 |
| Anton, RF; Cunningham, T; Lydiard, RB | 1 |
| Kupfer, DJ | 1 |
| Duman, RS; Nestler, EJ; Nibuya, M | 1 |
| Davidson, J; Fava, M; Halbreich, U; Harrison, W; Kocsis, JH; Koran, L; Rosenbaum, J; Thase, ME | 1 |
| Berndt, ER; Finkelstein, SN; Greenberg, PE; Keller, MB; Parsley, RA; Russell, JM | 1 |
| Davidson, J; Halbreich, U; Hellerstein, DJ; Kocsis, JH; Rosenbaum, J; Shelton, R; Yonkers, K; Zisook, S | 1 |
| Daniel, WA; Wójcikowski, J | 2 |
| Davidson, J; Halbreich, U; Koran, L; Pearlstein, T; Shelton, RC; Thase, ME; Yonkers, KA | 1 |
| Kamijima, K; Kiuchi, Y; Nara, K; Oguchi, K; Tadokoro, C; Yamazaki, Y | 1 |
| Fava, M; Nierenberg, AA; Pearlstein, T; Quitkin, FM; Rosenbaum, JF; Stone, A; Zisook, S | 1 |
| Agosti, V; Stewart, JW | 1 |
| Buni, TM | 1 |
| Ahern, D; Ball, SE; Kao, J; Scatina, J | 1 |
| Bergstrom, RF; Cerimele, BJ; Goldberg, MJ; Kurtz, DL | 1 |
| de Jonghe, F | 1 |
| Kamijima, K; Kiuchi, Y; Oguchi, K; Tadokoro, C; Yamazaki, Y | 1 |
| Bouwer, C; Stein, DJ | 1 |
3 review(s) available for imipramine and 1-naphthylamine
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
Management of recurrent depression.
Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Imipramine; Paroxetine; Psychotherapy; Recurrence; Sertraline | 1993 |
10 trial(s) available for imipramine and 1-naphthylamine
| Article | Year |
|---|---|
Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Aged; Chronic Disease; Depression; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
Childhood psychopathology retrospectively assessed among adults with early onset major depression.
Topics: 1-Naphthylamine; Adolescent; Adult; Anxiety Disorders; Child; Child Behavior Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Imipramine; Male; Mental Disorders; Middle Aged; Paroxetine; Personality Development; Phobic Disorders; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Chronic Disease; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Chronic Depression Study Group.
Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Depressive Disorder; Humans; Imipramine; Psychiatric Status Rating Scales; Sertraline; Task Performance and Analysis | 1996 |
Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes.
Topics: 1-Naphthylamine; Adult; Age of Onset; Aged; Antidepressive Agents; Double-Blind Method; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Patient Compliance; Placebos; Psychiatric Status Rating Scales; Quality of Life; Sertraline; Social Adjustment; Treatment Outcome | 1997 |
The undertreatment of dysthymia.
Topics: 1-Naphthylamine; Adult; Age of Onset; Aged; Ambulatory Care; Antidepressive Agents; Comorbidity; Dysthymic Disorder; Family; Female; Humans; Imipramine; Male; Mental Disorders; Middle Aged; Personality Disorders; Placebos; Prevalence; Psychiatric Status Rating Scales; Psychotherapy; Sertraline; Single-Blind Method; Treatment Outcome | 1997 |
A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
Topics: 1-Naphthylamine; Adult; Aged; Anger; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline | 1997 |
Six month follow-up of early-onset chronic depression.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Patient Discharge; Prognosis; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Treatment of dysthymia.
Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
The effect of sertraline on the pharmacokinetics of desipramine and imipramine.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Tricyclic; Area Under Curve; Chromatography, High Pressure Liquid; Cross-Over Studies; Desipramine; Half-Life; Humans; Imipramine; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
17 other study(ies) available for imipramine and 1-naphthylamine
| Article | Year |
|---|---|
Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds.
Topics: Binding Sites; Crystallography, X-Ray; Drug Stability; Humans; Kelch-Like ECH-Associated Protein 1; Ligands; Magnetic Resonance Spectroscopy; Microsomes; Molecular Dynamics Simulation; NF-E2-Related Factor 2; Protein Binding; Protein Interaction Maps; Small Molecule Libraries; Structure-Activity Relationship; Surface Plasmon Resonance | 2021 |
The effect of antidepressants on aversive periaqueductal gray stimulation in rats.
Topics: 1-Naphthylamine; Animals; Antidepressive Agents; Biogenic Monoamines; Dopamine; Dose-Response Relationship, Drug; Electric Stimulation; Fluvoxamine; Imipramine; Male; Nomifensine; Norepinephrine; Oximes; Periaqueductal Gray; Rats; Rats, Inbred Strains; Reinforcement, Psychology; Serotonin; Sertraline | 1990 |
[3H] sertraline binding to rat brain membranes.
Topics: 1-Naphthylamine; Animals; Brain; Fenclonine; Fluoxetine; Imipramine; In Vitro Techniques; Male; Membranes; Naphthalenes; Paroxetine; Piperidines; Rats; Receptors, Serotonin; Serotonin Antagonists; Sertraline | 1990 |
Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine.
Topics: 1-Naphthylamine; Animals; Autoradiography; Binding, Competitive; Brain; Fluoxetine; Imipramine; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Sertraline; Zimeldine | 1988 |
Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier.
Topics: 1-Naphthylamine; Alanine; Binding, Competitive; Blood Platelets; Cell Membrane; Humans; Imipramine; In Vitro Techniques; Naphthalenes; Receptors, Serotonin; Serotonin; Sertraline | 1988 |
Chronic antidepressant treatment down-regulates the induction of c-fos mRNA in response to acute stress in rat frontal cortex.
Topics: 1-Naphthylamine; Amino Acid Isomerases; Animals; Antidepressive Agents; Carrier Proteins; Desipramine; Down-Regulation; Frontal Lobe; Imipramine; Male; Peptidylprolyl Isomerase; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Restraint, Physical; RNA, Messenger; Sertraline; Stress, Psychological; Time Factors; Tranylcypromine | 1995 |
Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration.
Topics: 1-Naphthylamine; Animals; Citalopram; Hippocampus; Imipramine; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Time Factors | 1995 |
Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets.
Topics: 1-Naphthylamine; Blood Platelets; Calcium; Calmodulin; Cells, Cultured; Fluoxetine; Humans; Imipramine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Interactions between sertraline and tricyclic antidepressants.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Desipramine; Drug Interactions; Humans; Imipramine; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.
Topics: 1-Naphthylamine; Animals; Antidepressive Agents; Base Sequence; Blotting, Northern; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Desipramine; Electric Stimulation; Fluoxetine; Hippocampus; Imipramine; In Situ Hybridization; Male; Molecular Sequence Data; Nerve Growth Factors; Nerve Tissue Proteins; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptor, trkB; Receptors, Nerve Growth Factor; RNA, Messenger; Rolipram; Sertraline; Time Factors; Tranylcypromine | 1996 |
Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs.
Topics: 1-Naphthylamine; Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents, Tricyclic; Carbamazepine; Drug Interactions; Fluoxetine; Imipramine; Lysosomes; Male; Monensin; Phospholipids; Promazine; Psychotropic Drugs; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Tissue Distribution | 1997 |
Behavioral stimulation without alteration of beta and 5-HT receptors and adenylate cyclase activity in rat brain after chronic sertraline administration.
Topics: 1-Naphthylamine; Adenylyl Cyclases; Animals; Behavior, Animal; Binding, Competitive; Brain; Brain Chemistry; Cerebral Cortex; Cyclic AMP; Imipramine; Kinetics; Male; Neurotransmitter Uptake Inhibitors; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Fluoxetine; Fluvoxamine; Frozen Sections; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Lethal Dose 50; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Venlafaxine Hydrochloride | 1997 |
Sertraline and imipramine for the treatment of dysthymia.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Dysthymic Disorder; Humans; Imipramine; Placebos; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Interactions between promazine and antidepressants at the level of cellular distribution.
Topics: 1-Naphthylamine; Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Fluoxetine; Hydrogen-Ion Concentration; Imipramine; Lysosomes; Male; Promazine; Rats; Rats, Wistar; Sertraline | 1997 |
Effects of imipramine and sertraline on protein kinase activity in rat frontal cortex.
Topics: 1-Naphthylamine; Animals; Antidepressive Agents, Tricyclic; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cyclic AMP-Dependent Protein Kinases; Hippocampus; Imipramine; Male; Parietal Lobe; Prefrontal Cortex; Protein Kinase C; Protein Kinases; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Temporal Lobe | 1998 |
Survivors of torture presenting at an anxiety disorders clinic: symptomatology and pharmacotherapy.
Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Female; Humans; Imipramine; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; South Africa; Survivors; Torture; Treatment Outcome | 1998 |